Names | |
---|---|
Preferred IUPAC name
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | |
Identifiers | |
3D model (JSmol)
|
|
ChEBI | |
ChEMBL | |
ChemSpider | |
ECHA InfoCard | 100.044.475 |
EC Number |
|
KEGG | |
MeSH | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C12H15N | |
Molar mass | 173.259 g·mol−1 |
Melting point | 40 °C (104 °F; 313 K)[2] |
Boiling point | 128 to 132 °C (262 to 270 °F; 401 to 405 K) 12 Torr[1] |
Slightly soluble | |
Hazards | |
NFPA 704 (fire diamond) | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) is an organic compound. It is classified as a tetrahydropyridine. It is of interest as a precursor to the monoaminergic neurotoxin MPP+, which causes permanent symptoms of Parkinson's disease by destroying dopaminergic neurons in the substantia nigra of the brain. It has been used to study disease models in various animals.[3][4]
While MPTP itself has no psychoactive effects, the compound may be accidentally produced during the manufacture of MPPP, a synthetic opioid drug with effects similar to those of morphine and pethidine (meperidine). The Parkinson-inducing effects of MPTP were first discovered following accidental injection as a result of contaminated MPPP.